PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
PNU-100480 is being developed for the treatment of both drug resistant and sensitive
tuberculosis. This is an efficacy and safety study to characterize the effect of PNU-100480
when given for 14 days to treatment-naive patients with drug-sensitive pulmonary
tuberculosis.